Pharmacometric Analyses to Support Early Development Decisions for LY2878735: A Novel Serotonin Norepinephrine Reuptake Inhibitor

LY2878735 is a novel dual serotonin (5-hydroxytryptamine (5-HT)) and norepinephrine (NE) reuptake inhibitor (SNRI) in development for chronic pain indications. In vitro profile suggests a more balanced profile as compared with other SNRI's, which is expected to confer superior clinical efficacy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Raddad, E, Melhem, M R, Sloan-Lancaster, J S, Miller, J W, Van Wart, S A, Rubino, C M
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3828007/
https://ncbi.nlm.nih.gov/pubmed/23965782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/psp.2013.43
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados